Keros Therapeutics Inc.

KROS | NASDAQ

Price Alert Chart Builder DCF Calculator

$11.83

+$0.35 (+3.05%)

Sep 22, 2026, 2:19 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	87.01M	-187.35M	-152.99M	-104.68M	-58.74M	-45.36M
Depreciation & Amortization	1.51M	1.23M	815K	674K	378K	278K
Stock-Based Compensation	28.7M	34.87M	28.76M	18.68M	11.72M	4.1M
Other Working Capital	-8.29M	-8.59M	384K	-3.28M	-597K	2.21M
Other Non-Cash Items	2.4M	1.82M	1.56M	953K	520K	1.82M
Deferred Income Tax	n/a	n/a	n/a	n/a	46K	n/a
Change in Working Capital	-12.11M	-11.44M	-2.65M	14.31M	-16.07M	2.28M
Operating Cash Flow	107.51M	-160.87M	-124.51M	-70.06M	-62.15M	-36.89M
Capital Expenditures	-1.55M	-1.93M	-2.46M	-1.24M	-1.02M	-294K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-1.55M	-1.93M	-2.46M	-1.24M	-1.02M	-294K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	-375M	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	11.69M	3.13M	731K	379K	-3.16M
Financial Cash Flow	-378.47M	391.82M	178.96M	120.31M	28.55M	296.04M
Net Cash Flow	-272.52M	229.02M	51.98M	49.01M	-34.62M	258.86M
Free Cash Flow	105.95M	-162.8M	-126.97M	-71.3M	-63.17M	-37.19M
Adj. Free Cash Flow	77.26M	-197.67M	-155.74M	-89.99M	-74.89M	-41.29M
Maintenance CapEx	n/a	n/a	-2.3M	-1.24M	n/a	-294K
Growth CapEx	-1.55M	-1.93M	-166.32K	n/a	-1.02M	n/a
Owner Earnings	107.51M	-160.87M	-126.81M	-71.3M	-62.15M	-37.19M